Synapse - Steven Horwitz

Search Within

Steven M Horwitz

Results (3)

Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: Prolonged stable disease provides clinical benefits for patients in the pivotal trial

Journal Article

Foss, F.; Horwitz, S.; Pro, B.; Prince, H. M.; Sokol, L.; Balser, B.; Wolfson, J.; Coiffier, B.
Journal of Hematology & Oncology (2016)

Fulltext@MSK | Save

Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)

Meeting Abstract

Phillips, A.; Fields, P.; Hermine, O.; Taylor, G. P.; Delioukina, M.; Horwitz, S.; Ramos, J. C.; Meniane, J. C.; Barta, S. K.; Brites, C.; more...
Retrovirology (2015)

Fulltext@MSK | Save

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: Pivotal study update demonstrates durable responses

Journal Article

Coiffier, B.; Pro, B.; Prince, H. M.; Foss, F.; Sokol, L.; Greenwood, M.; Caballero, D.; Morschhauser, F.; Wilhelm, M.; Pinter-Brown, L.; more...
Journal of Hematology & Oncology (2014)

Fulltext@MSK | Save